LDX (ASX) LDX Discussion

Originally posted by Quest09: ↑

Another article just published.

May have to google to read the full article.

LDX getting some good news coverage.

Expand

Originally posted by Quest09: ↑

Yesterday's announcement is still currently under rated IMO (announcement shown as per below image). I don't think the market fully understands what it means to have the USA govt reimburse the cost of use for FebriDx.

The current Total Available Market (TAM) for the FebriDx product in the US is currently estimated to be US $118 million dollars per annum (as per below slide presentation screenshot). That TAM is reported to increase to 1.7 billion after the CLIA waiver is achieved (as per blow presentation slide).

The US govt has just endorsed the use of FebriDx to the extent that the US govt will reimburse clinicians for the cost of use for Febridx (as per below image of announcement).

As the below article screenshot indicates: "If there is positive incentive for adoption such as the clinician or facility getting paid, then they will use the product".

Basically, the US govt will pay clinicians to use FebriDx, and the current market size for the FebriDx product is about US $118 million dollars per annum, with plans to expand that market size to 1.7 billion per annum in the near future.

IMO, it is pretty clear that LDX revenue is expected to significantly increase as a result of this announcement.

IMO, LDX is currently significantly undervalued (as per above attached link to previous post).

Expand

Originally posted by Quest09: ↑

Are you looking for an entry. ?

IMO, we are heading UP.

Check out the below link....can't keep a good stock down..

What's more, we are expecting another significant announcement in the very near future (within December). Announcement could even drop monday morning (who knows.?).

Expand

Good to see a little soaking happening at this level. A transfer of shares from weak hands to more stoic hands who understand the upside potential available with LDX is required before the next leg up.

CLIA waiver clinical trial is due to start during December (or has already started), and an announcement to the market confirming the trial has begun could occur at any moment.

Onwards and upwards.
=)

Originally posted by Quest09: ↑

Yeah, fair enough. It's good to plan your entry, but IMO, we are heading up (see the two below attached posts for further details).

Also, yes, i do hold a decent size bag, and i appreciate your concern, but IMO there is no need for concern. I'm pretty comfortable with my position.

I say i hold a decent bag but that is ofcourse relative, and compared to Andrew "Twiggy" Forrest's investment company (Tenmile Ventures), my holding is insignificant. Tenmile bought up big just before the recent capital raise (45 million shares initially), and then i believe Tenmile topped up some more during the capital raise that followed.....so if Twiggy is comfortable with his holding and entry price at at 3.8 cents per share (currently trading at 3.9 cents), then i am certainly happy and comfortable with my holding and entry price.

Additionally, we can look at the top 20 holders as an indication of what the "big end of town" thinks of LDX. Top 20 holders own 63.09% of LDX ordinary fully paid shares, leaving only 36.91% of shares available for everyday punters like you and me. IMO, the proportion of shares owned by "smart money" (63.09%) is a vote of confidence in LDX and is further reason for me to feel comfortable with my position.

All IMO......and as i always say "each to their own".

Expand

Originally posted by Quest09: ↑

Just noticed a new account on YTube called "FebriDx CLIA".

The first and only video on the account just went up a few hours ago and is a 5 minute educational video on how to use FebriDx.

It seems like LDX has put out this video in preparation for the CLIA waiver study which is about to, or which has already started.

I guess LDX recognised that a short educational video on the use of FebriDx would help ensure that all users within the CLIA waiver study had easy access to a guide on the use of FebriDx.

IMO, this is a great sign that we should receive the news about the start of the CLIA waiver trial in the very near future.

Expand

Originally posted by Quest09: ↑

IMO, the timing of this is notable.

IMO, the issue of shares to Directors would likely occur before any potential significant rise in share price.....or put another way..... IMO, if LDX anticipated a significant rise in share price on the horizon, then LDX would issue shares to management before that rise in share price occured (as opposed to after).

So, IMO, the fact that shares were issued to an LDX Director at this point in time, just before the PLA reimbursement was announced, and just before the CLIA waiver begins, is a potential sign that LDX share price will begin to realise some of that upside potential which is clearly available.

Expand

No.	Vol.	Price($)
4	571666	2.8¢

No.

Vol.

Price($)

571666

2.8¢

Price($)	Vol.	No.
3.0¢	150000	1

Price($)

Vol.

No.

3.0¢

150000

No.	Vol.	Price($)
3	506666	0.028
3	318288	0.027
2	443000	0.026
6	601153	0.025
1	1238229	0.024

No.

Vol.

Price($)

506666

0.028

318288

0.027

443000

0.026

601153

0.025

1238229

0.024

Price($)	Vol.	No.
0.030	150000	1
0.031	250309	3
0.032	51725	1
0.033	190000	1
0.034	189253	1

Price($)

Vol.

No.

0.030

150000

0.031

250309

0.032

51725

0.033

190000

0.034

189253

(20min delay)
Last 2.9¢		Change 0.000(0.00%)		Mkt cap ! $21.70M

Open	High	Low	Value	Volume
2.9¢	2.9¢	2.9¢	$1.912K	65.93K

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Novo flags antimony and gold in the Pilbara – but does it need to step back?

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

Proteomics notches up as company launches PromarkerD into the US

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Top Stories

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Novo flags antimony and gold in the Pilbara – but does it need to step back?

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

Proteomics notches up as company launches PromarkerD into the US

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News